Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent

Journal of Drug Targeting

Volumn 19, Issue 8, 2011, Pages 657-665

  Chen, Zhijin ^a   Yu, Dexin ^b   Liu, Chunxi ^a   Yang, Xiaoyan ^a   Zhang, Na ^a   Ma, Chunhong ^a   Song, Jibin ^a   Lu, Zaijun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Biocompatible nanoparticles; Contrast agent; Gadolinium; Molecular MRI; Targeted

Indexed keywords

BIOMATERIAL; GADOLINIUM LABELED POLY(LEVO LACTIDE) BLOCK POLY(ETHYLENE GLYCOL); GADOLINIUM PENTETATE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CHELATION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG TARGETING; IN VIVO STUDY; LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CHROMATOGRAPHY, GEL; CONTRAST MEDIA; DRUG CARRIERS; GADOLINIUM; GADOLINIUM DTPA; HEP G2 CELLS; HUMANS; LACTATES; LIGHT; LIVER; MAGNETIC RESONANCE IMAGING; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, MOLECULAR; MOLECULAR IMAGING; MOLECULAR STRUCTURE; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; SCATTERING, RADIATION; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 80051747340     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2010.531727     Document Type: Article

References (29)

1. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. (2008). Factors afecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm, 5, 505-515.
2. Avgoustakis K. (2004). Pegylated poly(lactide) and poly(lactide-co- glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr Drug Deliv, 1, 321-333.
3. Chen Z, Yu D, Wang S, Zhang N, Ma C, Lu Z. (2009). Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent. Nanoscale Res Lett, 4, 618-626.
4. Cheng J, Teply BA, Sherif I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC. (2007). Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 28, 869-876. (Pubitemid 44667020)
5. de Marco G, Bogdanov A, Marecos E, Moore A, Simonova M, Weissleder R. (1998). MR imaging of gene delivery to the central nervous system with an artifcial vector. Radiology, 208, 65-71. (Pubitemid 28323311)
6. Doiron AL, Chu K, Ali A, Brannon-Peppas L. (2008). Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proc Natl Acad Sci USA, 105, 17232-17237.
7. Doiron AL, Homan KA, Emelianov S, Brannon-Peppas L. (2009). Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm Res, 26, 674-682.
8. Duarte MG, Gil MH, Peters JA, Colet JM, Elst LV, Muller RN, Geraldes C F. (2001). Synthesis, characterization, and relaxivity of two linear Gd(DTPA)-polymer conjugates. Bioconjug Chem, 12, 170-177. (Pubitemid 32235468)
9. Favier A, D'Agosto F, Charreyre MT, Pichot C. (2004). Synthesis of N-acryloxysuccinimide copolymers by RAFT polymerization, as reactive building blocks with full control of composition and molecular weights. Polymer, 45, 7821-7830. (Pubitemid 39370673)
10. Gindy ME, Prud'homme RK. (2009). Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv, 6, 865-878.
11. Lin YS, Hung Y, Su JK, Lee R, Chang C, Lin ML, Mou CY. (2004). Gadolinium(III)-incorporated nanosized mesoporous silica as potential magnetic resonance imaging contrast agents. J Phys Chem B, 108, 15608-15611.
12. Liu M, Li H, Luo G, Liu Q, Wang Y. (2008). Pharmacokinetics and biodistribution of surface modifcation polymeric nanoparticles. Arch Pharm Res, 31, 547-554.
13. Liu X, Xu YK, Huang QL. (2004). [Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions]. Di Yi Jun Yi Da Xue Xue Bao, 24, 15-17.
14. Mofat BA, Reddy GR, McConville P, Hall DE, Chenevert TL, Kopelman RR, Philbert M, Weissleder R, Rehemtulla A, Ross BD. (2003). A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol Imaging, 2, 324-332.
15. Moghimi SM, Davis SS. (1994). Innovations in avoiding particle clearance from blood by Kupfer cells: cause for refection. Crit Rev Ter Drug Carrier Syst, 11, 31-59.
16. Moghimi SM, Hunter AC, Murray JC. (2001). Long-circulating and target-specifc nanoparticles: theory to practice. Pharmacol Rev, 53, 283-318. (Pubitemid 32476118)
17. Moghimi SM, Porter CJ, Muir IS, Illum L, Davis SS. (1991). Non-phagocytic uptake of intravenously injected microspheres in rat spleen: infuence of particle size and hydrophilic coating. Biochem Biophys Res Commun, 177, 861-866.
18. Nakamura E, Makino K, Okano T, Yamamoto T, Yokoyama M. (2006). A polymeric micelle MRI contrast agent with changeable relaxivity. J Control Release, 114, 325-333. (Pubitemid 44376546)
19. Oja CD, Semple SC, Chonn A, Cullis PR. (1996). Infuence of dose on liposome clearance: critical role of blood proteins. Biochim Biophys Acta, 1281, 31-37. (Pubitemid 26178845)
20. Park JA, Kim HK, Kim JH, Jeong SW, Jung JC, Lee GH, Lee J, Chang Y, Kim TJ. (2010). Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg Med Chem Lett, 20, 2287-2291.
21. Paschkunova-Martic I, Kremser C, Mistlberger K, Shcherbakova N, Dietrich H, Talasz H, Zou Y, Hugl B, Galanski M, Sölder E, Pfaller K, Höliner I, Buchberger W, Keppler B, Debbage P. (2005). Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI). Histochem Cell Biol, 123, 283-301. (Pubitemid 40674679)
22. Swanson SD, Kukowska-Latallo JF, Patri AK, Chen C, Ge S, Cao Z, Kotlyar A, East AT, Baker JR. (2008). Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specifc magnetic resonance contrast enhancement. Int J Nanomedicine, 3, 201-210. (Pubitemid 352037852)
23. Tessmar JK, Mikos AG, Göpferich A. (2002). Amine-reactive biodegradable diblock copolymers. Biomacromolecules, 3, 194-200. (Pubitemid 34121175)
24. Turner JL, Pan DPJ, Plummer R, Chen ZY, Whittaker AK, Wooley KL. (2005). Synthesis of gadolinium-labeled shell-crosslinked nanoparticles for magnetic resonance imaging applications. Adv Funct Mater, 15, 1248-1254. (Pubitemid 41119967)
25. Unger E, Shen DK, Wu GL, Fritz T. (1991). Liposomes as MR contrast agents: pros and cons. Magn Reson Med, 22, 304-308; discussion 313.
26. Wang S, Jarrett BR, Kauzlarich SM, Louie AY. (2007). Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. J Am Chem Soc, 129, 3848-3856. (Pubitemid 46595506)
27. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. (2003). Tissue-specifc MR contrast agents. Eur J Radiol, 46, 33-44.
28. Xu ZP, Kurniawan ND, Bartlett PF, Lu GQ. (2007). Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles. Chemistry, 13, 2824-2830. (Pubitemid 46947959)
29. Zou W, Liu C, Chen Z, Zhang N. (2009). Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efcient gene therapy to lung cancer. Int J Pharm, 370, 187-195.